We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lithium Dilution Method in Guiding Fluid Therapy in Critically Ill Patients (LIGA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00626756
Recruitment Status : Unknown
Verified February 2008 by ASQA a.s..
Recruitment status was:  Recruiting
First Posted : February 29, 2008
Last Update Posted : February 29, 2008
Sponsor:
Information provided by:
ASQA a.s.

Brief Summary:
Hypothesis: Fluid management guided by LiDCO doesn´t increase cumulative fluid balance and shorten organ dysfunction compared to fluid management based on CVP and clinical judgment.

Condition or disease Intervention/treatment
Critical Illness Device: LiDCO technology

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: LIGA Trial-Lithium Dilution Method in Guiding Fluid Therapy in Critically Ill Patients
Study Start Date : January 2008
Estimated Primary Completion Date : December 2008

Arm Intervention/treatment
Experimental: LI
arm controled by LIDCO technology
Device: LiDCO technology
non invasive monitoring of cardiac output
No Intervention: CA
standard approach



Primary Outcome Measures :
  1. positive or negative fluid balance [ Time Frame: one year ]

Secondary Outcome Measures :
  1. effect of LiDCO monitoring on cumulative fluid balance [ Time Frame: one year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age
  • Needs for fluid chalange
  • Invasive ventilatory supportinvasive blood pressure monitoring
  • Lidco monitoring
  • Central venous catheter

Exclusion Criteria:

  • DNR
  • Need for CRRT
  • Head injury

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00626756


Contacts
Contact: Vladimir Cerny, MD cernyvla@fnhk.cz
Contact: Pavel Valek, MD +420272761350 pavel.valek@asqa.cz

Locations
Czech Republic
ASQA a.s. Recruiting
Prague, Czech Republic, 106 00
Contact: Pavel Valek, MD    +420272761350    pavel.valek@asqa.cz   
Principal Investigator: Vladimir Cerny, MD, PhD, FCCM         
Sponsors and Collaborators
ASQA a.s.
Investigators
Principal Investigator: Vladimir Cerny, MD, PhD, FCCM University Hospital Hradec Kralove

Publications:
Responsible Party: Pavel Valek M.D., ASQA a.s.
ClinicalTrials.gov Identifier: NCT00626756     History of Changes
Other Study ID Numbers: LigaStudy
LIGA2008
First Posted: February 29, 2008    Key Record Dates
Last Update Posted: February 29, 2008
Last Verified: February 2008

Keywords provided by ASQA a.s.:
fluid
Lidco technology
guided therapy
fluid management guided by Lidco technology

Additional relevant MeSH terms:
Critical Illness
Disease Attributes
Pathologic Processes